Financial Toxicity in Head and Neck Cancer Patients Treated With Proton Therapy by Grace L. Smith, MD, PhD, MPH, Ya-Chen Tina Shih, PhD, Steven J. Frank, MD

“…With increasing use of proton therapy as a curative treatment for head and neck cancer, the multifaceted financial and economic implications of proton therapy—dimensions of “financial toxicity”—need to be addressed. …”
Get full text

The Organ Sparing Potential of Different Biological Optimization Strategies in Proton Therapy by Helge Henjum, MSc, Tordis J. Dahle, PhD, Lars Fredrik Fjæra, MSc, Eivind Rørvik, MSc, Sara Pilskog, PhD, Camilla H. Stokkevåg, PhD, Andrea Mairani, PhD, Kristian S. Ytre-Hauge, PhD

“…Our aim was to compare several biological optimization strategies for proton therapy by evaluating their performance in different clinical cases. …”
Get full text

The Effect of Phantom Compositions on Dose Calculations in Proton Therapy of Liver Cancer by Zahra Ahmadi Ganjeh, Mohammad Eslami-Kalantari, Ali Asghar Mowlavi

Subjects: “…proton therapy…”
Get full text

Investigating the effects of a range shifter on skin dose in proton therapy by Ming Wang, Lei Zhang, Jinxing Zheng, Guodong Li, Wei Dai, Lang Dong

Subjects: “…Proton therapy facility…”
Get full text

Spot Weight Adaptation for Moving Target in Spot Scanning Proton Therapy by Paul eMorel, Xiaodong eWu, Guillaume eBlin, Guillaume eBlin, Stéphane eVialette, Ryan eFlynn, Daniel eHyer, Dongxu eWang

Subjects: “…intensity-modulated proton therapy…”
Get full text

Achromatic beamline design for a laser-driven proton therapy accelerator by K. D. Wang, K. Zhu, Matthew J. Easton, Y. J. Li, C. Lin, X. Q. Yan

“…A new laser-driven proton therapy facility is being designed by Peking University. …”
Get full text

Adjuvant Reirradiation With Proton Therapy in Head and Neck Squamous Cell Carcinoma by Kristin Hsieh, MD, Alexandra Elena Hotca, MD, Daniel R. Dickstein, MD, Eric J. Lehrer, MD, Celina Hsieh, MD, Vishal Gupta, MD, Kunal K. Sindhu, MD, Jerry T. Liu, MD, Samuel H. Reed, PA-C, Arpit Chhabra, MD, Krzysztof Misiukiewicz, MD, Scott Roof, MD, Mohemmed Nazir Kahn, MD, Diana Kirke, MD, Mark Urken, MD, Marshall Posner, MD, Eric Genden, MD, Richard L. Bakst, MD

“…Given an absence of clear consensus on the role of adjuvant re-RT, we sought to assess histopathologic risk factors of patients with HNSCC and their resulting outcomes after adjuvant re-RT with proton therapy. Methods and Materials: We conducted a retrospective analysis of patients with HNSCC who underwent salvage surgery at our institution followed by adjuvant re-RT with proton therapy over 1.5 years. …”
Get full text

Dose-response of deformable radiochromic dosimeters for spot scanning proton therapy by Simon V. Jensen, Lia B. Valdetaro, Per R. Poulsen, Peter Balling, Jørgen B.B. Petersen, Ludvig P. Muren

Subjects: “…Proton therapy…”
Get full text

Assessment of Knowledge-Based Planning for Prostate Intensity Modulated Proton Therapy by Yihang Xu, BS, Nellie Brovold, MS, Jonathan Cyriac, MS, Elizabeth Bossart, PhD, Kyle Padgett, PhD, Michael Butkus, PhD, Tejan Diwanj, MD, Adam King, MS, Alan Dal Pra, MD, Matt Abramowitz, MD, Alan Pollack, MD, Nesrin Dogan, PhD

“…Purpose: To assess the performance of a proton-specific knowledge based planning (KBPP) model in creation of robustly optimized intensity-modulated proton therapy (IMPT) plans for treatment of patients with prostate cancer. …”
Get full text

Proton therapy in the treatment of diffuse astrocytoma of the brain stem. Case report by T. A. Kireeva, Yu. V. Gumenetskaya, D. V. Gogolin, K. B. Gordon, I. A. Gulidov, O. G. Lepilina

“…The patient received the complete course of proton therapy. After 36 months of follow-up, no complications and signs of disease progression were found.Conclusion. …”
Get full text

Monte Carlo Simulation of TRIM Algorithm in Ceramic Biomaterial in Proton Therapy by Fatih Ekinci, Tunc Asuroglu, Koray Acici

“…However, their predisposition to proton therapy, which is a trending treatment in the world, has not been adequately studied. …”
Get full text

The impact of breathing amplitude on dose homogeneity in intensity modulated proton therapy by Angjelina Protik, Marcel van Herk, Marnix Witte, Jan-Jakob Sonke

“…Background/purpose: Intensity-modulated proton therapy (IMPT) dose distributions can be severely degraded in targets moving with respiration due to the interplay, range and blurring effects. …”
Get full text

Current Perspectives on Proton Therapy: Techniques Shaping the Future of Cancer Treatment by Tamalika Chakraborty, Ammar A Razzak Mahmood, Jyoti Kataria, Amutha Chellathurai, Vanitha Innocent Rani, Muthu Prasanna

“…Thus, there is a need for wide usage of Proton Therapy (PT) for successive cancer treatment. The present review focuses on PT based on tumour site, clinical studies, biological barriers, instrumentation of PT, significance, and limitations.…”
Get full text

Exploring patient-reported barriers to participating in proton therapy clinical trials by Anne Wilhøft Kristensen, Annesofie Lunde Jensen, Kenneth Jensen, Susanne Oksbjerre Dalton, Jeppe Friborg, Cai Grau

Subjects: “…Proton therapy…”
Get full text

Dosimetric effects of the supine and prone positions in proton therapy for prostate cancer by Takahiro Kato, Masato Kato, Kimihiro Takemasa, Masao Murakami

Subjects: Get full text

Catalytic activity imperative for nanoparticle dose enhancement in photon and proton therapy by Lukas R. H. Gerken, Alexander Gogos, Fabian H. L. Starsich, Helena David, Maren E. Gerdes, Hans Schiefer, Serena Psoroulas, David Meer, Ludwig Plasswilm, Damien C. Weber, Inge K. Herrmann

Get full text

Metallacarboranes for proton therapy using research accelerators: a pilot study by Teresa Pinheiro, Luís C. Alves, Victoria Corregidor, Francesc Teixidor, Clara Viñas, Fernanda Marques

Get full text

Estimating Potential Benefits to Neurocognition with Proton Therapy in Adults with Brain Tumors by Mariana Petruccelli, MD, Amy Parent, MRT(T), Michael Holwell, MRT(T), Hitesh Dama, MRT(T), Grace Tsui, MRT(T), Zhihui Amy Liu, PhD, Derek S. Tsang, MD, MSc

Subjects: Get full text

Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience by Ronik S. Bhangoo, MD, Trey C. Mullikin, MD, Jonathan B. Ashman, MD, PhD, Tiffany W. Cheng, BA, Michael A. Golafshar, MS, Todd A. DeWees, PhD, Jedediah E. Johnson, PhD, Satomi Shiraishi, PhD, Wei Liu, PhD, Yanle Hu, PhD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, Sunil Krishnan, MD, William G. Rule, MD, Terence T. Sio, MD, Christopher L. Hallemeier, MD

“…Purpose: Our purpose was to assess the safety and efficacy of intensity modulated proton therapy (IMPT) for the treatment of hepatocellular carcinoma (HCC). …”
Get full text

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy by Marika Musielak, Wiktoria M. Suchorska, Magdalena Fundowicz, Piotr Milecki, Julian Malicki

Subjects: “…proton therapy…”
Get full text